Qingdao Baheal Medical INC. Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Qingdao Baheal Medical INC. Stock Forecast and Price Target
If the average 2024 price target of ¥51.00 recently set by prominent experts for Qingdao Baheal Medical INC. is met, there would be a potential upside of approximately 57.65% from the last closing price in May, 2024. The high estimate is ¥51.00, and the low is ¥51.00. If interested in 301015 stock, you may also want to consider its competitors.
57.65% Upside
Qingdao Baheal Medical INC. Fair Value Forecast for 2023 - 2025 - 2030
In the last year, Qingdao Baheal Medical INC.'s Price has decreased from ¥17.85 to ¥0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach ¥0.00 – an increase of 100.00%. For the next six years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 601607 Stock Forecast | Shanghai Pharmaceuticals Holdi... | Outperform |
18
|
¥17.92 | Buy/Sell | ¥20.67 | 22.77% |
| 000963 Stock Forecast | Huadong Medicine | Buy |
18
|
¥32.94 | Buy/Sell | ¥52.40 | 34.34% |
| 1099 Stock Forecast | Sinopharm Group | Buy |
18
|
HK$19.42 | Buy/Sell | HK$25.81 | 28.63% |
| 874 Stock Forecast | Guangzhou Baiyunshan Pharmaceu... | Outperform |
16
|
HK$21.90 | Buy/Sell | HK$24.33 | 4.34% |
| 600998 Stock Forecast | Jointown Pharmaceutical Group | Outperform |
18
|
¥8.21 | Buy/Sell | ¥7.70 | 33.98% |
Qingdao Baheal Medical INC. Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Qingdao Baheal Medical INC.'s Revenue has grown, rising from ¥5.88B to ¥7.56B – a growth of 28.65%. For the following year, the 0 analysts predict that Qingdao Baheal Medical INC.'s Revenue will drop by 7.81%, reaching ¥6.97B. In 2030, the professionals' prediction is that 301015's Revenue will decrease by 5.45%, reaching ¥7.15B.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600511 Stock Forecast | China National Medicines | Buy |
18
|
¥34.75 | Buy/Sell | ¥46.57 | 27.48% |
| 600056 Stock Forecast | China Meheco Group | - |
18
|
¥10.38 | Buy/Sell | ¥17.87 | 22.93% |
| 000078 Stock Forecast | Shenzhen Neptunus Bioengineeri... | - |
13
|
¥2.33 | Buy/Sell | ¥9.24 | -100.00% |
.jpg)
Qingdao Baheal Medical INC. Dividend per Share Forecast for 2023 - 2025 - 2030
Qingdao Baheal Medical INC.'s Dividend per Share has grown In the last year, rising from ¥0.67 to ¥0.76 – a growth of 13.43%. In the following year, the 0 analysts surveyed believe that Qingdao Baheal Medical INC.'s Dividend per Share will decrease by 11.84%, reaching ¥0.67. According to professionals, by 2030, Qingdao Baheal Medical INC.'s Dividend per Share will have decreased by 7.01%, falling down to ¥0.71.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 603368 Stock Forecast | Guangxi LiuYao Group | Buy |
18
|
¥17.95 | Buy/Sell | ¥0.00 | 41.06% |
| 002589 Stock Forecast | Realcan Pharmaceutical Group | - |
11
|
¥2.68 | Buy/Sell | ¥11.80 | -100.00% |
| 000705 Stock Forecast | Zhejiang Zhenyuan Share | - |
18
|
¥8.27 | Buy/Sell | ¥0.00 | -100.00% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1345 Stock Forecast | Shanghai Pioneer Holding Ltd | - |
18
|
HK$1.85 | Buy/Sell | HK$2.93 | -100.00% |
| 2289 Stock Forecast | Charmacy Pharmaceutical | - |
14
|
HK$13.98 | Buy/Sell | HK$8.72 | -100.00% |
| 6833 Stock Forecast | Sinco Pharmaceuticals Holdings | - |
12
|
HK$0.24 | Buy/Sell | HK$0.46 | -100.00% |
Qingdao Baheal Medical INC. EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Qingdao Baheal Medical INC.'s EBITDA has grown by 123.35%, rising from ¥433.48M to ¥968.17M. According to the 0 analysts polled, in the next year, Qingdao Baheal Medical INC.'s EBITDA will fall by 23.13%, reaching ¥744.20M. By 2030, professionals believe that Qingdao Baheal Medical INC.'s EBITDA will have decreased by 20.96%, falling to ¥765.24M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1110 Stock Forecast | Kingworld Medicines Group | - |
0
|
HK$0.54 | Buy/Sell | HK$0.00 | -100.00% |
| BIMI Stock Forecast | BIMI International Medical | - |
4
|
$2.91 | Buy/Sell | $0.00 | -100.00% |
| 1011 Stock Forecast | China NT Pharma Group Company | - |
0
|
HK$0.03 | Buy/Sell | HK$1.95 | -100.00% |
Qingdao Baheal Medical INC. EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Qingdao Baheal Medical INC.'s EBIT has grown, moving from ¥414.47M to ¥938.23M – an increase of 126.37%. For the next year, 0 analysts project Qingdao Baheal Medical INC.'s EBIT to drop by 23.45%, reaching ¥718.18M. By 2030, professionals believe that Qingdao Baheal Medical INC.'s EBIT will decrease by 21.14%, reaching ¥739.90M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 2211 Stock Forecast | Universal Health International... | - |
-7
|
HK$0.05 | Buy/Sell | HK$29.30 | -100.00% |
| CNBI Stock Forecast | China BCT Pharmacy Group | - |
0
|
$0.00 | Buy/Sell | $0.00 | 0.00% |
| GPHG Stock Forecast | Global Pharm Holdings Group | - |
0
|
0.00 | Buy/Sell | 0.00 | 0.00% |
Qingdao Baheal Medical INC. EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last year, Qingdao Baheal Medical INC.'s EPS has decreased from ¥1.19 to ¥0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach ¥0.00 – an increase of 100.00%. For the next six years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)